HCW Biologics Inc Cash Flow-to-Debt Ratio
HCW Biologics Inc cash flow-to-debt ratio. HCW Biologics Inc (HCWB) has a Cash Flow-to-Debt Ratio of -0.21x as of June 2026, meaning its operating cash flow of $-3.97 Million could theoretically repay 0% of its total liabilities ($19.34 Million) in one year. Check HCW Biologics Inc cash earnings quality to evaluate the quality of earnings relative to operating cash generation.
CF-to-Debt Ratio
Operating Cash Flow
Total Liabilities
Data as of
Cash Flow-to-Debt Ratio of HCW Biologics Inc (2019–2025)
Cash flow-to-debt ratio of HCW Biologics Inc from 2019 to 2025. Historical debt coverage capacity for HCW Biologics Inc across 7 annual periods. Also explore HCWB net assets growth trend to track the company's year-over-year net asset growth rate.
HCW Biologics Inc Cash Flow-to-Debt Ratio by Year (2019–2025)
HCW Biologics Inc cash flow-to-debt ratio by year from 2019 to 2025. Year-by-year debt coverage analysis for HCW Biologics Inc. For the full cash flow conversion analysis, see cash efficiency ratio of HCW Biologics Inc.
| Year | CF-to-Debt Ratio | Operating CF (USD) | Total Liabilities | YoY Change |
|---|---|---|---|---|
| 2025 | -0.62x | $-13.39 Million | $21.76 Million | ▼ -60.1% |
| 2024 | -0.38x | $-14.23 Million | $37.01 Million | ▲ +74.3% |
| 2023 | -1.50x | $-22.51 Million | $15.05 Million | ▼ -35.1% |
| 2022 | -1.11x | $-10.39 Million | $9.38 Million | ▲ +76.6% |
| 2021 | -4.73x | $-10.98 Million | $2.32 Million | ▲ +54.6% |
| 2020 | -10.42x | $-10.43 Million | $1.00 Million | ▼ -64.2% |
| 2019 | -6.35x | $-6.77 Million | $1.07 Million | — |